We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe

MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry

MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry

Scope

Coding, payment mechanism tariffs

Countries
14 EU
Pricing
On request
Availability
On-demand
Scope

Pathway to create or improve reimbursement situation

Countries
14 EU
Pricing
On request
Availability
On-demand
Scope

Stakeholders, money flow, payment model, HTA landscape, funding, reimbursement pathway

Countries
14 EU
Pricing
1500€
Availability
Off-the-shelf
Scope

One day, on-site training on key aspects of market access

Countries
14 EU
Pricing
5000€
Availability
On-demand
Scope

Coding, payment mechanism tariffs for a specific procedure

Countries
11 EU
Pricing
On request
Availability
Off-the-shelf

Why us?

Analyses from the same vendor for 14 different EU countries
Analyses from the same vendor for 14 different EU countries

Save money and time, get standardized analysis

Pharma approach is put aside
Pharma approach is put aside

Work with a company truly specialized in medical devices and diagnostics

Getting results instantly (reports) or within 4-8 weeks (services)
Getting results instantly (reports) or within 4-8 weeks (services)

Make business decisions quickly

12 out of top-30 companies choose MTRC for reimbursement support
12 out of top-30 companies choose MTRC for reimbursement support

Work with a provider who understand industry’s needs

More than 110 projects accomplished during the last year
More than 110 projects accomplished during the last year

Work with a provider who has experience in your field

Team of 15 specialists in 6 countries
Team of 15 specialists in 6 countries

Work with a provider with a Pan-European capacity

More than 200 internal instructions and protocols
More than 200 internal instructions and protocols

Be sure about quality of the results

To stay up-to-date, we daily monitor developments of reimbursement systems in Europe

Subscribe to our newsletter to get updates every 2nd week

01 Jun 2018
European Med Tech and IVD Reimbursement Consulting Ltd. released a report, which identifies and provides an overview of the innovative payment schemes for medical devices and in-vitro diagnostic tests in European countries. The report was supported by the grant from the Med Tech Europe. Access the full version of the report at our web-site.

13

Jul 2018

The report presents a summary of the reimbursement situation for vagus nerve stimulation. Indications include epilepsy and depression. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

13

Jul 2018

On the 14th of May of 2018, Norwegian RHF Decision Forum (Beslutningsforum) has recommended usage of the Flash Glucose Monitoring system - Freestyle Libre for the treatment and follow-up of children (less than 18 years) with type 1 diabetes and other types of diabetes.

12

Jul 2018

On 31st of May, 2018, the Catalan agency for quality and health evaluation, AQuAS, has published an update on the efficacy, effectiveness, safety and cost-effectiveness of the proton therapy for the treatment of cancer.

11

Jul 2018

In the second half of May, the National Institute for Health and Care Excellence (NICE) published two new interventional procedure guidance for low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy and endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cancer.

Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 14 European countries

Analysis

Reimbursement

  • Availability of procedure / reimbursement code
  • Reimbursement mechanism (diagnosis-related group or fee for service)
  • Availability of add-on reimbursement
  • Availability of innovation funding
  • Reimbursement tariffs

National funding

Willingness to pay for technology, based on:

  • Statements from national commissioners (e.g., NHS England)
  • Health Benefit Catalogues (e.g. in Spain, LEA Levels in Italy)
  • National clinical guidance (e.g. NICE in the UK, Haute Autorité de Santé in France, Socialstyrelsen in Sweden)
  • National health technology assessments in connection with reimbursement decisions (e.g. NICE for Technology Appraisal in the UK, Haute Autorité de Santé in France)
  • Specific funding frameworks (e.g., “New method” in Norway)
Strategy

Reimbursement strategy

Pathway to get reimbursement:

  • Overview of drivers and barriers for adoption
  • Overview of key reimbursement and funding pathways (including state-sponsored studies and innovation funding)
  • Detailed presentation of individual pathways (process, stakeholders, requirements, timelines)
  • Action plan

Check our specific propositions for: Med Tech industry, IVD industry, Investors

Our services cover 14 European countries, including Austria, Belgium, Denmark, England, Finland, France, Germany, Italy, the Netherlands, Norway, Russia, Spain, Sweden and Switzerland

We provide services for major types of medical technologies

Implantable devices

Interventional procedures

Non-in­ter­ven­tional procedures

In-vitro diagnostic tests

Medical aids

Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring and insulin injection, use of fusidial markers, radiotherapy, endoscopy and more

Confidence in results

We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:

  • Standard Operating Procedures and Work Instructions
  • Access to official coding and DRG manuals, tariff lists and grouping software
  • A team comprised of experienced Clinical Coders with a medical background
  • Quick access to health authorities to address uncertainties
  • Ongoing research program to get insights from payer and provider interviews
  • All reports are reviewed by the CEO before release

Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • Transcatheter aortic valve implantation (TAVI) 
  • Eight minimally invasive and transcatheter mitral valve repair and replacement technologies
  • Group of peripheral vascular arterial interventions (angioplasty, angioplasty using drug-eluting balloon, stenting using bare metal and drug-eluting stents, atherectomy, periperal IVUS)
  • Robotic surgery interventions
  • Peripheral venous interventions for deep vein thrombosis and venous insufficiency
  • Coronary percutaneous revascularization (angioplasty using plain and drug-coated balloon, bare metal and drug-eluting stents, mechanical thrombectomy, percutaneous atherectomy)
  • Coronary percutaneous imaging procedures (angiography, IVUS, FFR, OCT)
  • Mechanical thrombectomy for stroke
  • Ablation of heart tissue for atrial fibrillation
  • Radiotherapy procedures (all types)
  • Surgical and endovascular treatment of brain aneurysm
  • Ventricular assist devices (VADs) for cardiac failure
  • Extra-corporeal membrane oxygenation (ECMO) for cardiac and respiratory failure

Ongoing reports:

  • Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Hospital and out-patient remote monitoring for neurostimulators
  • Percutaneous ablation procedures for diseases of lung, prostate, kidney and bone
  • Deep brain stimulation
  • Spinal cord stimulation
  • Vagus nerve stimulation
  • Bariatric surgery
  • Hernia repair
  • Vascular access for long-term use: AV fistula and AV graft